biogem: Support

Support

BIOGEM is funded in part through the following sources:

Transcriptional Genomics Core Facility for the UCSD/UCLA Diabetes and Endocrinology Research Center (DERC) consortium

NIH/NIDDK - Award 1 P30 DK063491-03

A major goal in efforts to understand the mechanisms by which signal transduction pathways regulate programs of gene expression is to identify their direct target genes in response to regulatory signals The BIOGEM CORE Facility provides services to advance such efforts, conventional microarray analysis and promoter microarray analysis.

LIPID Metabolites And Pathways Strategy (LIPID MAPS)

NIH/GM - LIPID MAPS Award U54 GM 069338-03

Sequencing of the human genome has opened the way and provided the impetus for building a comprehensive picture of a mammalian cell. Significant efforts are underway in the fields of genomics and proteomics to identify all genes and proteins in a given organism. The goal is a complete map of the genes, gene products and their interaction networks in a functioning cell. The next step in establishing a comprehensive picture of a cell will be to tie the cell's metabolome into the rapidly developing genomic and proteomic maps. A cell's metabolome, however, is such an enormous and complex entity that characterizing it can only be approached in sections. This consortium is now proposing to focus on the lipid section of the metabolome by developing an integrated metabolomic system capable of characterizing the global changes in lipid metabolites ("lipidomics"). Our consortium has developed a Lipid Metabolites and Pathways Strategy, termed LIPID MAPS, that applies a global integrated approach to the study of lipidomics. The Macrophage Biology and Functional Genomics Core is a component of the LIPID MAPS consortium.

The Biomedical Genomics Facility gratefully acknowledges support from the UCSD Center for Human Genetics/Genomics and The Moore's Cancer Center at UCSD.

For further information regarding funding, please contact BIOGEM at (858) 822-4231.

Last Updated March 2008
By Dr. Gary Hardiman